Competition guidance: vaccines for global epidemics, preclinical stage 2 development

Organisations can apply for a share of £15 million (including VAT) to develop vaccine candidates and technologies in line with UK Vaccine Network priorities.



These guidance notes complement the invitation to tender (document SBRI_DH_344_001) which can be found on the FTP site, and are designed to help with completing the application form.

Please read the full competition scope in the competition brief before you make your application.

Published 4 June 2018